- Home
- GOSS vs API Comparison
GOSS vs API Comparison
Compare GOSS & API Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- API
- Stock Information
- Founded
- GOSS 2015
- API 2013
- Country
- GOSS United States
- API United States
- Employees
- GOSS N/A
- API N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- API Computer Software: Prepackaged Software
- Sector
- GOSS Health Care
- API Technology
- Exchange
- GOSS Nasdaq
- API Nasdaq
- Market Cap
- GOSS 347.8M
- API 343.2M
- IPO Year
- GOSS 2019
- API 2020
- Fundamental
- Price
- GOSS $2.47
- API $3.45
- Analyst Decision
- GOSS Strong Buy
- API Strong Buy
- Analyst Count
- GOSS 4
- API 1
- Target Price
- GOSS $8.50
- API $6.00
- AVG Volume (30 Days)
- GOSS 3.1M
- API 508.9K
- Earning Date
- GOSS 08-05-2025
- API 08-18-2025
- Dividend Yield
- GOSS N/A
- API N/A
- EPS Growth
- GOSS N/A
- API N/A
- EPS
- GOSS N/A
- API N/A
- Revenue
- GOSS $40,237,000.00
- API $133,554,000.00
- Revenue This Year
- GOSS N/A
- API $7.20
- Revenue Next Year
- GOSS $30.65
- API $11.26
- P/E Ratio
- GOSS N/A
- API N/A
- Revenue Growth
- GOSS N/A
- API N/A
- 52 Week Low
- GOSS $0.66
- API $1.78
- 52 Week High
- GOSS $2.65
- API $6.99
- Technical
- Relative Strength Index (RSI)
- GOSS 68.08
- API 40.21
- Support Level
- GOSS $2.38
- API $3.48
- Resistance Level
- GOSS $2.65
- API $3.67
- Average True Range (ATR)
- GOSS 0.15
- API 0.19
- MACD
- GOSS 0.03
- API -0.02
- Stochastic Oscillator
- GOSS 76.67
- API 10.17
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About API Agora Inc.
Agora Inc provides real-time communication solutions. The company offers real-time video calling, voice calling, live audio and video streaming, recording, and real-time messaging. It serves the gaming, retail, and education industries. The company operates in the People's Republic of China and the United States of America and the majority of its revenue is derived from the People's Republic of China.